Evolus (EOLS) Retained Earnings (2018 - 2026)
Evolus (EOLS) posted Retained Earnings of $643.2 million for Q1 2026, up 412414.1% on a QoQ basis from -$156000.0 in Q4 2025, and up 76763.89% year-over-year from N/an in Q1 2025.
Evolus (EOLS) Retained Earnings (2018 - 2026) Analysis & Trends
Evolus' Retained Earnings history runs 9 years deep, the most recent figure standing at $643.2 million for Q1 2026.
- Quarterly Retained Earnings rose 76763.89% year-over-year to $643.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $643.2 million (up 76763.89% YoY) and the FY2025 annual result came in at -$156000.0, down 100.03% from the prior year.
- Retained Earnings was $643.2 million for Q1 2026 at Evolus, up from -$156000.0 in the prior quarter.
- Across five years, Retained Earnings topped out at $643.2 million in Q1 2026 and bottomed at -$602.6 million in Q3 2024.
- A 5-year average of $140.0 million and a median of -$103000.0 in 2022 frame the typical range for Retained Earnings.
- Peak annual rise in Retained Earnings reached 504419.42% in 2023, while the deepest fall reached 208.3% in 2023.
- Evolus' Retained Earnings stood at $516.1 million in 2022, then plunged by 208.3% to -$559.0 million in 2023, then jumped by 210.17% to $615.8 million in 2024, then sank by 100.03% to -$156000.0 in 2025, then soared by 412414.1% to $643.2 million in 2026.
- Business Quant data shows EOLS's Retained Earnings at $643.2 million in Q1 2026, -$156000.0 in Q4 2025, and $632.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 37.04 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 28.20 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.11 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 4.54 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 8.83 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -1.81 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 18.66 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 589.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -2.13 Bn |
| 10 | Evolus | 390.47 Mn | 340.68 Mn | 48.90 Mn | 643.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 643.21 Mn |
| Dec 31, 2025 | -156,000.00 |
| Sep 30, 2025 | 632.55 Mn |
| Jun 30, 2025 | -599,000.00 |
| Mar 31, 2025 | -839,000.00 |
| Dec 31, 2024 | 615.83 Mn |
| Sep 30, 2024 | -602.61 Mn |
| Jun 30, 2024 | -601,000.00 |
| Mar 31, 2024 | 591.09 Mn |
| Dec 31, 2023 | -558.98 Mn |
| Sep 30, 2023 | -547.15 Mn |
| Jun 30, 2023 | 523.73 Mn |
| Mar 31, 2023 | 519.45 Mn |
| Dec 31, 2022 | 516.13 Mn |
| Sep 30, 2022 | 513.72 Mn |
| Jun 30, 2022 | -463.85 Mn |
| Mar 31, 2022 | -103,000.00 |
| Dec 31, 2021 | 504.76 Mn |
| Sep 30, 2021 | -404.71 Mn |
| Jun 30, 2021 | 491.41 Mn |